Kala Bio annual capital expenditures (capex)
2015
2016
2017
2018
2019
2022
2023
2024
2025
Kala Bio Capital Expenditures (CapEx) Growth & History (KALA)
Kala Bio's capital expenditures (capex) was $15,000 for fiscal 2025.
View full Kala Bio company overviewKala Bio annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $15,000 | −$193,000 | −92.79% |
| 2024 | 2024-12-31 | $208,000 | −$402,000 | −65.90% |
| 2023 | 2023-12-31 | $610,000 | $297,000 | +94.89% |
| 2022 | 2022-12-31 | $313,000 | — | — |
| 2019 | 2019-12-31 | $1.3M | −$243,000 | −15.40% |
| 2018 | 2018-12-31 | $1.6M | $1.1M | +228.75% |
| 2017 | 2017-12-31 | $480,000 | $327,000 | +213.73% |
| 2016 | 2016-12-31 | $153,000 | −$99,000 | −39.29% |
| 2015 | 2015-12-31 | $252,000 | — | — |
Kala Bio quarterly capital expenditures (capex)
Q3.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $69,000 | — | — |
| Q3 2020 | 2020-09-30 | $544,000 | $340,000 | +166.67% |
| Q2 2020 | 2020-06-30 | $623,000 | $124,000 | +24.85% |
| Q1 2020 | 2020-03-31 | $292,000 | −$152,000 | −34.23% |
| Q4 2019 | 2019-12-31 | $188,000 | −$722,000 | −79.34% |
| Q3 2019 | 2019-09-30 | $204,000 | $77,000 | +60.63% |
| Q2 2019 | 2019-06-30 | $499,000 | $331,000 | +197.02% |
| Q1 2019 | 2019-03-31 | $444,000 | $71,000 | +19.03% |
| Q4 2018 | 2018-12-31 | $910,000 | $628,000 | +222.70% |
| Q3 2018 | 2018-09-30 | $127,000 | $38,000 | +42.70% |
| Q2 2018 | 2018-06-30 | $168,000 | $131,000 | +354.05% |
| Q1 2018 | 2018-03-31 | $373,000 | $301,000 | +418.06% |
| Q4 2017 | 2017-12-31 | $282,000 | — | — |
| Q3 2017 | 2017-09-30 | $89,000 | $40,000 | +81.63% |
| Q2 2017 | 2017-06-30 | $37,000 | — | — |
| Q1 2017 | 2017-03-31 | $72,000 | — | — |
| Q3 2016 | 2016-09-30 | $49,000 | — | — |
Kala Bio capital expenditures (capex) trends
Between the periods ended 2015-12-31 and 2025-12-31, Kala Bio's capital expenditures (capex) decreased from $252,000 to $15,000, a change of −$237,000. The latest reported quarter, Q4 2024, shows $69,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kala Bio source filings ↗